Please login to the form below

Not currently logged in
Email:
Password:

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

Dynavax Natale RicciardiNatale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer.

Ricciardi spent 39 years at Pfizer, advancing to president of the pharma giant's global manufacturing business and senior VP of its North American operations.

He was also a member of the Pfizer executive leadership team when he retired in 2011.

Dynavax, which focuses on developing products to prevent and treat infectious and inflammatory diseases, will benefit from this senior experience as it looks to bring to market its lead product candidate, the hepatitis B vaccine Heplisav.

"On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman of the board at Dynavax.

“His experienced leadership, particularly in global manufacturing, will provide valuable insight to the company and we look forward to his contributions."

10th July 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics